Remission Evaluation of Metabolic Interventions in Type 2 Diabetes (REMIT Pilot Trial)
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this pilot trial is to determine whether an intensive treatment with insulin
glargine, metformin, acarbose and lifestyle can normalize blood glucose levels in patients
with recently diagnosed type 2 diabetes mellitus when compared to standard diabetes care.